COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics’ New Organic Cannabis Operation Receives Cultivation License for Outdoor Grow Area
15/07/2019
Emerald an early mover in outdoor cannabis growing with license enabling cultivation in 2019 at 12-acre grow area in British Columbia VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
XORTX Shares Nature Nephrology Review
15/07/2019
Clinical Studies Confirm Causal Relationship Between Uric Acid and Chronic Kidney Disease CALGARY, Alberta, July 15, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: [...]
Todos Medical Announces Positive Alzheimer's Biomarker Clinical Data from LymPro vs. Amyloid PET Interim Analysis
15/07/2019
REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostic company focused on the development of blood tests for the early detection of cancer and [...]
RedHill Biopharma to Host Second Quarter 2019 Financial Results Conference Call on July 23, 2019
15/07/2019
TEL-AVIV, Israel and RALEIGH, N.C., July 15, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Cerecor Announces First Patient Enrolled in CDG FIRST Trial
15/07/2019
-A Retrospective Study on Congenital Disorders of Glycosylation ROCKVILLE, Md., July 15, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and [...]
Livongo Announces Launch of Initial Public Offering
15/07/2019
MOUNTAIN VIEW, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Livongo) today announced that it plans to commence the roadshow for its proposed initial public offering. Livongo has filed a registration [...]
Zosano Pharma Presents Migraine-ACT Scores for Qtrypta™ at the American Headache Society (AHS) Annual Scientific Meeting
15/07/2019
Migraine Assessment of Current Therapy (or Migraine-ACT) Scores Highlight the Effectiveness of Qtrypta in Treating Migraines FREMONT, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a [...]
Neon Therapeutics’ Personal Neoantigen Vaccine Study Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, Non-Small Cell Lung and Bladder Cancers
15/07/2019
NEO-PV-01, in combination with OPDIVO® (nivolumab), broadens the immune response to specific new cancer targets, leading to the first demonstration of improved clinical durability for a personal neoantigen-based therapy [...]
Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular Dystrophy
15/07/2019
--Interim Analysis Showed Statistically Significant Improvements in the Performance of the Upper Limb, Grip Strength and Inspiratory Flow Reserve in the Randomized Double-Blind Placebo Controlled Study -- --Company to [...]
Arrayit Corporation Announces Allergy Testing Services Network Expansion to Multiple Clinics in Hawaii
15/07/2019
Sunnyvale, July 15, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has expanded its national allergy testing services network to include several new clinics [...]
Orphazyme appoints Kim Stratton as Chief Executive Officer
15/07/2019
Kim Stratton to succeed Anders Hinsby, effective October 1, 2019 Copenhagen, July 15, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
Sanofi: information concerning the total number of voting rights and shares, June 2019
15/07/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juin 2019
15/07/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Aino Health AB (publ): Aino Health AB signs partnership agreement with EFESO Consulting Nordics
15/07/2019
Aino Health and EFESO Consulting, a worldwide leader in operational excellence consulting, has signed a partnership agreement where EFESO Nordics will sell licenses and implementation services for Aino’s health [...]
Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim
15/07/2019
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that it has submitted a meeting [...]
Eurobio Scientific: Bilan Semestriel du Contrat de Liquidite
15/07/2019
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE PAR EUROBIO SCIENTIFIC AVEC LOUIS CAPITAL MARKETS Paris, le 15 juillet 2019 – 8h00 Au titre du contrat de liquidité portant sur les actions de la société Eurobio [...]
GILEAD AND GALAPAGOS ENTER INTO TRANSFORMATIVE RESEARCH AND DEVELOPMENT COLLABORATION
14/07/2019
- Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment - - Gilead Gains Access to Galapagos' Differentiated Drug Discovery Platform and Current and Future Pipeline Outside of Europe - - [...]
BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019
13/07/2019
July 13, 2019 Announcement no. 14 BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019 [...]
Aras Azadian, Setu Purohit and Kyle Langstaff Announce Positions in Avicanna Inc.
13/07/2019
TORONTO, July 12, 2019 (GLOBE NEWSWIRE) -- This news release is being disseminated as required by National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection [...]

Pages